Clinical Trials Browser

Phase 3 × fludarabine phosphate × 90 days × Clear all

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

Multiple Myeloma

Clinical Trials